Historical record - last NADAC publication: 7/20/2016
Product Information
NEFAZODONE HCL 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.4593 per EA under NDC 00093102606. Its NADAC has been published 195 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093102606
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
7/20/2016
Active Ingredients
NEFAZODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076037On Market Since
9/16/2003
Pharmacological Classes
Price Statistics
The NADAC for NEFAZODONE HCL 250 MG TABLET has been published 195 times since Nov 28, 2013, and over the history we have for it it has risen 167.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4593 per EA |
|---|---|
| All-time high | $1.4593 (Aug 16, 2017) |
| All-time low | $0.5137 (Dec 18, 2013) |
| Median price | $1.0600 |
| Average price | $1.0389 |
| Largest weekly change | +39.6% (Dec 17, 2014) |
| Weeks tracked | 195 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Nefazodone Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NEFAZODONE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEFAZODONE HCL 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.4593 per EA (NDC 00093102606), effective Aug 16, 2017.
How has the price of NEFAZODONE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEFAZODONE HCL 250 MG TABLET has risen 167.6%. It has been tracked across 195 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEFAZODONE HCL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for NEFAZODONE HCL 250 MG TABLET has ranged from a low of $0.5137 (Dec 18, 2013) to a high of $1.4593 (Aug 16, 2017), with a median of $1.0600 per EA.
Are there cheaper alternatives to NEFAZODONE HCL 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NEFAZODONE HCL 250 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures NEFAZODONE HCL 250 MG TABLET?
NEFAZODONE HCL 250 MG TABLET (NDC 00093102606) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification